Author: Publisher:
ISBN:
Category :
Languages : en
Pages :
Book Description
Company Profiles: Dowell Property Holdings Limited
Company Profiles: Glorious Property Holdings Limited
Author: Company Profiles: Eastern Property Holdings Limited
Author: Company Profiles: Physical Property Holdings Inc
Author: Understanding Business Valuation
Author: Gary R. TrugmanPublisher: John Wiley & Sons
ISBN: 1119483646
Category : Business & Economics
Languages : en
Pages : 1253
Book Description
This fifth edition simplifies a technical and complex area of practice with real-world experience and examples. Expert author Gary Trugman's informal, easy-to-read style, covers all the bases in the various valuation approaches, methods, and techniques. Author note boxes throughout the publication draw on Trugman's veteran, practical experience to identify critical points in the content. Suitable for all experience levels, you will find valuable information that will improve and fine-tune your everyday activities.
In the Shadow of the Dragon
Author: Winter NiePublisher: AMACOM Div American Mgmt Assn
ISBN: 0814431704
Category : Business & Economics
Languages : en
Pages : 305
Book Description
The ômade in Chinaö label has long dominated the lower end of the US manufacturing industry, effectively squeezing it out of existence. That's old news. What most people don't know is that China's global reach now extends much further. Chinese companies have entered higher-end marketsùtechnology, financial services, transportation, energyùand are emerging as powerhouse multinationals. In the Shadow of the Dragon is a meticulously researched exposT of the most competitive companies in China. Based on interviews with Chinese business leaders and original case studies, the book provides: ò Profiles of key players ò Insights into subtle yet powerful strategies used to gain market dominance ò An understanding of the Chinese approach to going global ò Analysis of the Chinese way of innovation ò Advice on competing head-to-head or forming alliances with Chinese partners Part primer, part survival guide, In the Shadow of the Dragon is the first book to lay bare the challenges looming ahead.
Nelson's Directory of Institutional Real Estate
Author: Publisher:
ISBN:
Category : Real estate investment
Languages : en
Pages : 2012
Book Description
Fever Vision
Author: Gene HayworthPublisher:
ISBN:
Category : Biography & Autobiography
Languages : en
Pages : 268
Book Description
From his birth in rural Kentucky during the Great Depression to his suicide in Manhattan in 1985, Coleman Dowell played many roles. He was a songwriter and lyricist for television. He was a model. He was a Broadway playwright. He served in the U.S. Army, both abroad and at home. And most notably, he was the author of novels that Edmund White, among others, has called "masterpieces." But Dowell was deeply troubled by a depression that hung over him his entire life. Pegged as both a Southern writer and a gay writer, he loathed such categorization, preferring to be judged only by his work. Fever Vision describes one of the most tormented, talented, and inventive writers of recent American literature, and shows how his eventful life contributed to the making of his incredible art.
Pain Management and the Opioid Epidemic
Author: National Academies of Sciences, Engineering, and MedicinePublisher: National Academies Press
ISBN: 0309459575
Category : Medical
Languages : en
Pages : 483
Book Description
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
Author: